Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses.
| Author | Abu-Raddad, Laith J |
| Author | Chemaitelly, Hiam |
| Author | Yassine, Hadi M |
| Author | Benslimane, Fatiha M |
| Author | Al Khatib, Hebah A |
| Author | Tang, Patrick |
| Author | Malek, Joel A |
| Author | Coyle, Peter |
| Author | Ayoub, Houssein H |
| Author | Al Kanaani, Zaina |
| Author | Al Kuwari, Einas |
| Author | Jeremijenko, Andrew |
| Author | Kaleeckal, Anvar Hassan |
| Author | Latif, Ali Nizar |
| Author | Shaik, Riyazuddin Mohammad |
| Author | Abdul Rahim, Hanan F |
| Author | Nasrallah, Gheyath K |
| Author | Al Kuwari, Mohamed Ghaith |
| Author | Al Romaihi, Hamad Eid |
| Author | Al-Thani, Mohamed H |
| Author | Al Khal, Abdullatif |
| Author | Butt, Adeel A |
| Author | Bertollini, Roberto |
| Available date | 2021-10-20T11:14:33Z |
| Publication Date | 2021-10-11 |
| Publication Name | Journal of Travel Medicine |
| Identifier | http://dx.doi.org/10.1093/jtm/taab083 |
| Citation | Laith J Abu-Raddad, PhD, Hiam Chemaitelly, MSc, Hadi M Yassine, PhD, Fatiha M Benslimane, PhD, Hebah A Al Khatib, PhD, Patrick Tang, MD PhD, Joel A Malek, PhD, Peter Coyle, MD, Houssein H Ayoub, PhD, Zaina Al Kanaani, PhD, Einas Al Kuwari, MD, Andrew Jeremijenko, MD, Anvar Hassan Kaleeckal, MSc, Ali Nizar Latif, MD, Riyazuddin Mohammad Shaik, MSc, Hanan F Abdul Rahim, PhD, Gheyath K Nasrallah, PhD, Mohamed Ghaith Al Kuwari, MD, Hamad Eid Al Romaihi, MD, Mohamed H Al-Thani, MD, Abdullatif Al Khal, MD, Adeel A Butt, MD, Roberto Bertollini, MD MPH, Pfizer-BioNTech mRNA BNT162b2 Covid-19 vaccine protection against variants of concern after one versus two doses, Journal of Travel Medicine, Volume 28, Issue 7, October 2021, taab083, https://doi.org/10.1093/jtm/taab083 |
| ISSN | 1195-1982 |
| Abstract | Strategies for rolling out vaccination against Coronavirus Disease 2019 (Covid-19) varied across countries. A key question is whether delaying administration of the second vaccine dose to vaccinate the largest number of people in the shortest time, in situations of limited vaccine supplies and high incidence, could avert more disease cases, hospitalizations and deaths than the current protocol of a second dose shortly after the first dose. |
| Language | en |
| Publisher | Oxford University Press |
| Subject | B1.1.7 B1.617.2 SARS-CoV-2 alpha variant beta variant delta variant |
| Type | Article |
| Issue Number | 7 |
| Volume Number | 78 |
| ESSN | 1708-8305 |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Sciences [638 items ]
-
COVID-19 Research [741 items ]